Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori*. Pantoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The standard adult dose is one pack taken twice daily for 7 to 14 days. Each pack typically contains:
* Pantoprazole 40 mg
* Amoxicillin 500 mg
* Clarithromycin 250 mg
## Pediatric Dosing
There is no established pediatric dosing for Sompraz hp. Dosing of individual components may be considered in specific circumstances under expert guidance.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for pantoprazole or amoxicillin based on renal function. However, caution is advised in severe renal impairment. Clarithromycin dosing should be reduced in severe renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** No specific dose adjustment is recommended for pantoprazole or amoxicillin. Clarithromycin should be used with caution in moderate to severe hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use with cisapride, ergot alkaloids, midazolam, pimozide, or other drugs that are known to prolong the QT interval.
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia) may increase the risk of QT prolongation.
* Severe renal impairment (for amoxicillin, not typically a contraindication for the combination unless severe).
## Adverse Effects
Common adverse effects include diarrhea, nausea, headache, abdominal pain, taste perversion, rash, and fungal superinfections. More serious adverse effects include:
* *Clostridioides difficile*-associated diarrhea (CDAD).
* QT prolongation and arrhythmias (especially with clarithromycin).
* Severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis).
* Hepatotoxicity.
* Hypersensitivity reactions.
## Key Drug Interactions
* **Pantoprazole:** Can decrease the absorption of drugs that require an acidic environment (e.g., ketoconazole, iron salts). May interact with warfarin.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can significantly increase serum concentrations of drugs metabolized by CYP3A4 (e.g., statins, certain calcium channel blockers, anticonvulsants, anticoagulants, some antivirals). Avoid concomitant use with cisapride, pimozide, ergot alkaloids, and certain benzodiazepines.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Assess for *Clostridioides difficile*-associated diarrhea.
* Monitor for signs of hepatotoxicity and QT prolongation.
* Evaluate for therapeutic response (e.g., resolution of symptoms, confirmation of *H. pylori* eradication via testing if indicated).
## Clinical Pearls
* Administer the pack 30 minutes before a meal.
* Ensure completion of the full course of therapy, even if symptoms improve.
* Educate patients on potential side effects, including diarrhea and the importance of reporting severe or persistent symptoms.
* For patients with penicillin allergy, alternative *H. pylori* eradication regimens should be considered.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making clinical decisions.*
